Treatment with VK0214 led to Significant Reductions in Plasma and Tissue Levels of VLCFAs
Good news. ABCD2 making steady progress...
Viking Therapeutics Announces Top-Line Results ... - AMN EASIER
Viking Therapeutics Announces Top-Line Results from Proof-of-Concept Study of VK0214 in In Vivo Model of X-Linked Adrenoleukodystrophy
Written by
wilburlois15
To view profiles and participate in discussions please or .
1 Reply
•
Pretty cool. Thanks so much for sharing!
Not what you're looking for?
You may also like...
Cell-based Gene Therapy Represents ‘Hope’ for X-ALD Patients, Review Study Suggests
Definitely hopeful for the future of ALD/AMN!
https://adrenoleukodystrophynews.com/2019/11/12/cell-
Fish oil (DHA) + Lorenzo's oil
of X-ALD [21]. Supplementation with DHA, is therefore strongly recommended in patients with X-ALD...
Tauroursodeoxycholic acid
inhibiting the unfolded protein response in X-linked adrenoleukodystrophy...
Moderation team
COwithAMNAdministrator
